About Us

Sound Choice Pharmaceutical Institute (SCPI) is a non-profit organization with a mission to end human trafficking and exploitation for the purposes of biomedical research and commercial products. Our President and Founder, Dr. Theresa Deisher Ph.D., has over 30 years of pharmaceutical research and leadership experience. She discovered the adult stem cell, has worked on their therapeutic uses as an alternative to human fetal DNA, and leads a team of scientists at AVM Biotechnology dedicated to changing what a diagnosis of cancer, autoimmunity, or chronic infectious disease means to patients and their loved ones. As a result of this work, Dr. Deisher is named as an inventor on over 47 patents.

Under her leadership, the SCPI organization

§ Studies the health and pathologic consequences of residual fetal human DNA, cellular debris, and retroviruses and medicines,

§ Promotes awareness about the widespread use of fetal human material in drug discovery, development and commercialization, and the rights of every consumer to know what is in their products, including residual human DNA,

§ Supports the gains made in adult stem cell research, and

§ Conducts research into alternative treatments and products which are ethically acceptable

Donations from our supporters enable us to continue our work. You can join us by subscribing to our newsletter, helping us fund and continue our research, or sharing this information with friends.

DR. THERESA DEISHER

Dr. Deisher’s career has focused on discovering and developing new therapies for grievous human illness. Dr. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University and has spent over 30 years in commercial biotechnology. Prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute (SCPI), she worked with leading biotechnology companies, including Genentech, Repligen, ZymoGenetics, Immunex, and Amgen. AVM Biotechnology does not use morally illicit material in any process and develops products that improve outcomes without additional suffering, because side effects from treatments of cancers or infections should never be worse than the diseases themselves. SCPI’s mission is to end human trafficking in biomedical research.

Dr. Deisher is an inventor on 47 issued US/EU/Japan patents and 3 discoveries in clinical trials. She was the first to discover adult cardiac derived stem cells and has been a champion of adult stem cell research. Dr. Deisher was a plaintiff in the US federal lawsuit to prohibit the use of federal tax-payer dollars for embryo-destructive research, which was instrumental in steering science towards adult stem cell research.

She is a frequent lecturer on stem cell issues and the medical and ethical concerns with the use of aborted human fetal DNA in vaccine production. She has appeared on numerous radio and television shows.

Comments are closed.